Modulation of interleukin-16 by interferon β-1a treatment in patients with multiple sclerosis

被引：0
作者：
Nischwitz, S. [1 ]
Saemann, P. G. [1 ]
Knop, M. [1 ]
Mueller-Sarnowski, F. [1 ]
Faber, H. [1 ]
Yassouridis, A. [1 ]
Weber, F. [1 ]
机构：
[1] Max Planck Inst Psychiat, D-80804 Munich, Germany
来源：
JOURNAL OF NEUROLOGY | 2010年 / 257卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P663
引用
收藏
页码：S218 / S219
页数：2
相关论文
共 50 条
  • [21] Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferonβ 1a
    Eckart Schott
    Friedemann Paul
    Jens T Wuerfel
    Frauke Zipp
    Birgit Rudolph
    Bertram Wiedenmann
    Daniel C Baumgart
    World Journal of Gastroenterology, 2007, (26) : 3638 - 3640
  • [22] Quality of life in multiple sclerosis:: influence of interferon-β1a (Avonex®) treatment
    Vermersch, P
    de Seze, J
    Delisse, B
    Lamaire, S
    Stojkovic, T
    MULTIPLE SCLEROSIS JOURNAL, 2002, 8 (05) : 377 - 381
  • [23] Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferonβ 1a
    Schott, Eckart
    Paul, Friedemann
    Wuerfel, Jens T.
    Zipp, Frauke
    Rudolph, Birgit
    Wiedenmann, Bertram
    Baumgart, Daniel C.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (26) : 3638 - 3640
  • [24] Case of Type 1 Diabetes Mellitus Following Interferon β-1a Treatment for Multiple Sclerosis
    Uonaga, Taeko
    Yoshida, Kenichi
    Harada, Takanari
    Shimodahira, Makiko
    Nakamura, Yoshio
    INTERNAL MEDICINE, 2012, 51 (14) : 1875 - 1877
  • [25] Comparison of interferon β-1a subcutaneous and interferon β-1b on medication adherence in patients with multiple sclerosis
    Joyeux, A.
    Meletiche, D.
    Kozma, C.
    Dickson, M.
    Bennett, R.
    JOURNAL OF NEUROLOGY, 2009, 256 : S162 - S163
  • [26] 1H-MRS in patients with multiple sclerosis undergoing treatment with interferon β-1a:: results of a preliminary study
    Sarchielli, P
    Presciutti, O
    Tarducci, R
    Gobbi, G
    Alberti, A
    Pelliccioli, GP
    Orlacchio, A
    Gallai, V
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (02) : 204 - 212
  • [27] Azathioprine and interferon β1a in relapsing-remitting multiple sclerosis patients:: Increasing efficacy of combined treatment
    Lus, G
    Romano, F
    Scuotto, A
    Accardo, C
    Cotrufo, R
    EUROPEAN NEUROLOGY, 2004, 51 (01) : 15 - 20
  • [28] Affinity maturation of antibodies against interferon-β in patients with multiple sclerosis treated with interferon β-1a
    Basuroski, I. Dujmovic
    Deisenhammer, F.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S244 - S245
  • [29] The use of interferon β-1a in children and adolescents with multiple sclerosis
    Pohl, D
    Gärtner, J
    Rostasy, K
    ANNALS OF NEUROLOGY, 2003, 54 : S152 - S152
  • [30] Neuropsychological effects of interferon β-1a in relapsing multiple sclerosis
    Fischer, JS
    Priore, RL
    Jacobs, LD
    Cookfair, DL
    Rudick, RA
    Herndon, RM
    Richert, JR
    Salazar, AM
    Goodkin, DE
    Granger, CV
    Simon, JH
    Grafman, JH
    Lezak, MD
    Hovey, KMO
    Perkins, KK
    Barilla-Clark, D
    Schacter, M
    Shucard, DW
    Davidson, AL
    Wende, KE
    Bourdette, DN
    Kooijmans-Coutinho, MF
    ANNALS OF NEUROLOGY, 2000, 48 (06) : 885 - 892
12345